Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2091 of 6351
-
Electric zaps to the brain may help veterans remember words
Symptom relief CompletedA debilitating and common symptom in Gulf War Illnesses (GWI) is the inability to retrieve words. This affects one's conversations, ability to fluidly exchange information verbally and retrieve information from memory. The investigators have discovered 3 brain regions - the PreSu…
Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Virtual reality vs. strength training: which boosts arm function in cerebral palsy?
Symptom relief CompletedVirtual reality (VR) has shown to be effective to improve arm function in children with cerebral palsy (CP). Recently, functional strength training (FST) starts to show to improve arm function in patients with stroke but has not been extensively explored in children with CP. This…
Sponsor: Georgia State University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Experimental liposomal chemo shows promise in kids with relapsed leukemia
Disease control CompletedThis is a pilot study utilizing Marqibo® (vincristine sulfate liposome injection) combined with dexamethasone, mitoxantrone and asparaginase (UK ALL R3) for relapsed acute lymphoblastic leukemia (ALL).
Phase 1 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug combo aims to boost immune attack on melanoma
Disease control CompletedThis phase I trial studies the best dose of ibrutinib when given together with pembrolizumab in treating patients with stage III-IV melanoma that cannot be removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attac…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug duo aims to outsmart stubborn cancers
Disease control OngoingHyPeR is a multi-centre Phase 1 Dose Escalation Study of Guadecitabine (SGI-110)/ASTX727 a Second Generation Hypo-Methylating Agent in Combination with Pembrolizumab (MK3475) in Patients with Refractory Solid Tumours. The investigators will be investigating the safety and toxicit…
Phase 1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Weight loss program aims to cut cancer risk in BRCA and lynch syndrome carriers
Disease control OngoingThis trial studies how well weight management and health behavior intervention works in helping patients with hereditary breast and ovarian cancer and Lynch syndrome mutation carriers lose or maintain a healthy weight and lower their risk for cancer. Lifestyle behaviors such as p…
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immune booster before chemo shows promise for tough breast cancer
Disease control OngoingThis study is a 2-cohort, open-label, multicenter, phase 2 study of a short course of immunotherapy consisting of sequential decitabine followed by pembrolizumab administered prior to a standard neoadjuvant chemotherapy regimen for patients with locally advanced HER2-negative bre…
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a vitamin d pill help kids with kidney disease avoid dialysis?
Disease control Stopped earlyPrimary Objective: Evaluated the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH). Secondary Objectives: * Evaluated the safety profile of Hectorol® capsules versus Rocaltrol® (calcitriol) capsules. * Determined the pharmacokinetic …
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for brain tumor patients: targeted drug shows promise in early trial
Disease control CompletedThis is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132 mutations.
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Blood test may guide heart failure treatment to cut hospital returns
Diagnosis CompletedHeart failure (HF) is a severe disease, burdened with a poor prognosis (30% mortality at 2 years, 30% of rehospitalization within 1 month). It is also a major cause of health burden representing between 1.5 and 2 billions euros per year in France. Approximately 75% of these costs…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Can a glass of pomegranate juice tame gut inflammation?
Disease control CompletedThe aim of this research is to study the effects of a pomegranate juice on calprotectin levels in patients suffering of inflammatory bowel disease (IBD) in clinical remission. Fecal calprotectin levels, surrogate marker of mucosal inflammation, will be measured from baseline to 1…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Spine radiation showdown: one big blast or three small doses?
Symptom relief OngoingThe goal of this clinical research study is to learn whether delivering spine radiosurgery in a single large dose is better than delivering spine radiosurgery over 3 smaller doses. Researchers also want to learn about the effects of a single dose on participant's symptoms, pain,…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Could a simple MRI spare young patients from invasive liver biopsies?
Knowledge-focused Recruiting nowAutoimmune liver diseases (AILD), which include Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH) are a common etiological factors for chronic liver disease among adolescents. In all these conditions, autoimmune lymphocyte responses are thought to orchestrate in…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Nicotine patch trial aims to boost memory in seniors
Disease control CompletedThe purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI. Neuronal nicotinic receptors have long been known to play a critical role in memory function in preclinical s…
Phase 2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug cocktail shows promise for rare bone marrow cancer
Disease control CompletedThis is a Phase 1b, open-label, non-randomized, multicenter, dose-finding study evaluating venetoclax in combination with azacitidine in participants with treatment-naïve higher-risk MDS comprising a dose-escalation portion and a safety expansion portion.
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a diabetes drug tame obesity caused by brain tumor treatment?
Disease control CompletedThis hypothalamic obesity is associated with serious metabolic and psychosocial consequences. The purpose of the study is to compare the change of body weight after 6 months treatment with a lifestyle intervention + exenatide compare to the one after the same lifestyle intervent…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a single DNA test solve the mystery of rare brain diseases in kids?
Knowledge-focused CompletedLeukodystrophies, and other heritable disorders of the white matter of the brain, were previously resistant to genetic characterization, largely due to the extreme genetic heterogeneity of molecular causes. While recent work has demonstrated that whole genome sequencing (WGS), ha…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Could a pill replace infusions for gaucher brain symptoms?
Disease control OngoingPart 1: Biomarker evaluation/screening phase Primary Objectives: * Evaluate cerebrospinal fluid (CSF) biomarkers in adult Gaucher disease Type 3 (GD3) participants that distinguish GD3 from adult Gaucher disease Type 1 (GD1) participants * Screen adult GD3 participants who qual…
Phase 2 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can we predict how kids with IBD will respond to treatment?
Knowledge-focused Recruiting nowThe purpose of this study is to analyse effectiveness and safety signals of current treatment strategies in routine practice for patients with pediatric-onset inflammatory bowel disease (PIBD) and to correlate this to their individual risk factors.
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Kickoff for heart health: can casual football get inactive men fit?
Prevention CompletedThe aim of this study was to examine the health and physical fitness effects of 12 weeks of recreational football in inactive 30-50-year-old men. This was a two-arm, parallel-group randomized controlled trial with a 1:2 allocation ratio to either a control group, which was inform…
Sponsor: University of Southern Denmark • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC